Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03989206
PHASE3

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

Sponsor: Galderma R&D

View on ClinicalTrials.gov

Summary

Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description

Official title: A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects With Moderate-to-Severe Atopic Dermatitis

Key Details

Gender

All

Age Range

12 Years - Any

Study Type

INTERVENTIONAL

Enrollment

1935

Start Date

2019-12-30

Completion Date

2026-08-31

Last Updated

2026-10-20

Healthy Volunteers

No

Interventions

DRUG

Nemolizumab

Nemolizumab

Locations (343)

Galderma Investigational Site 8749

Birmingham, Alabama, United States

Galderma Investigational Site 8893

Birmingham, Alabama, United States

Galderma Investigational Site 8866

Guntersville, Alabama, United States

Galderma Investigational Site 8808

Scottsdale, Arizona, United States

Galderma Investigational Site 8873

Scottsdale, Arizona, United States

Galderma Investigational Site 8447

Fort Smith, Arkansas, United States

Galderma Investigational Site 8880

North Little Rock, Arkansas, United States

Galderma Investigational Site 8831

Anaheim, California, United States

Galderma Investigational Site 8906

Bell Gardens, California, United States

Galderma Investigational Site 8456

Beverly Hills, California, United States

Galderma Investigational Site 8578

Cerritos, California, United States

Galderma Investigational Site 8577

Encinitas, California, United States

Galderma Investigational Site 8636

Fountain Valley, California, United States

Galderma Investigational Site 8224

Fremont, California, United States

Galderma Investigational Site 8791

Fresno, California, United States

Galderma Investigational Site 8888

Fullerton, California, United States

Galderma Investigational Site 8845

Huntington Beach, California, United States

Galderma Investigational Site 8833

Inglewood, California, United States

Galderma Investigational Site 8686

Lomita, California, United States

Galderma Investigational Site 8674

Los Angeles, California, United States

Galderma Investigational Site 8683

Los Angeles, California, United States

Galderma Investigational Site 8813

Los Angeles, California, United States

Galderma Investigational Site 8907

Newport Beach, California, United States

Galderma Investigational Site 8799

Ontario, California, United States

Galderma Investigational Site 8745

Pasadena, California, United States

Galderma Investigational Site 8671

San Diego, California, United States

Galderma Investigational Site 8692

San Diego, California, United States

Galderma Investigational Site 8658

San Diego, California, United States

Galderma Investigational Site 8125

San Francisco, California, United States

Galderma Investigational Site 8536

Santa Ana, California, United States

Galderma Investigational Site 8608

Santa Monica, California, United States

Galderma Investigational Site 8820

Westminster, California, United States

Galderma Investigational Site 8637

Farmington, Connecticut, United States

Galderma Investigational Site 8870

Boca Raton, Florida, United States

Galderma Investigational Site 8805

Cape Coral, Florida, United States

Galderma Investigational Site 8786

Clearwater, Florida, United States

Galderma Investigational Site 8902

Doral, Florida, United States

Galderma Investigational Site 8391

Hialeah, Florida, United States

Galderma Investigational Site 8804

Hialeah, Florida, United States

Galderma Investigational Site 8711

Jacksonville, Florida, United States

Galderma Investigational Site 8836

Jacksonville, Florida, United States

Galderma Investigational Site 8523

Largo, Florida, United States

Galderma Investigational Site 8850

Margate, Florida, United States

Galderma Investigational Site 8719

Miami, Florida, United States

Galderma Investigational Site 8851

Miami, Florida, United States

Galderma Investigational Site 8656

Miami, Florida, United States

Galderma Investigational Site 8801

Miami, Florida, United States

Galderma Investigational Site 8704

Miami, Florida, United States

Galderma Investigational Site 8737

Miami, Florida, United States

Galderma Investigational Site 8706

Miami, Florida, United States

Galderma Investigational Site 8708

Miami, Florida, United States

Galderma Investigational Site 8806

Miami Lakes, Florida, United States

Galderma Investigational Site 8800

Miami Lakes, Florida, United States

Galderma Investigational Site 8856

Ormond Beach, Florida, United States

Galderma Investigational Site 8734

Pembroke Pines, Florida, United States

Galderma Investigational Site 8203

Tampa, Florida, United States

Galderma Investigational Site 8816

Tampa, Florida, United States

Galderma Investigational Site 8889

Tampa, Florida, United States

Galderma Investigational Site 8839

Tampa, Florida, United States

Galderma Investigational Site 8126

West Palm Beach, Florida, United States

Galderma Investigational Site 8667

Columbus, Georgia, United States

Galderma Investigational Site 8744

Macon, Georgia, United States

Galderma Investigational Site 8728

Newnan, Georgia, United States

Galderma Investigational Site 8707

Stockbridge, Georgia, United States

Galderma Investigational Site 8819

Nampa, Idaho, United States

Galderma Investigational Site 9916

Chicago, Illinois, United States

Galderma Investigational Site 8739

Normal, Illinois, United States

Galderma Investigational Site 8729

Rolling Meadows, Illinois, United States

Galderma Investigational Sites 8571

Skokie, Illinois, United States

Galderma Investigational Site 8712

Skokie, Illinois, United States

Galderma Investigational Site 8142

Indianapolis, Indiana, United States

Galderma Investigational Site 8724

New Albany, Indiana, United States

Galderma Investigational Site 9934

Shawnee Mission, Kansas, United States

Galderma Investigational Site 8771

Louisville, Kentucky, United States

Galderma Investigational Site 8882

Bangor, Maine, United States

Galderma Investigational Site 8743

Ann Arbor, Michigan, United States

Galderma Investigational Site 8512

Bay City, Michigan, United States

Galderma Investigational Site 8554

Detroit, Michigan, United States

Galderma Investigational Site 8617

Farmington Hills, Michigan, United States

Galderma Investigational Site 8155

Troy, Michigan, United States

Galderma Investigational Site 8849

Troy, Michigan, United States

Galderma Investigational Site 8226

Warren, Michigan, United States

Galderma Investigational Site 8748

Ypsilanti, Michigan, United States

Galderma Investigational Site 8521

Saint Joseph, Missouri, United States

Galderma Investigational Site 8718

Missoula, Montana, United States

Galderma Investigational Site 8810

Omaha, Nebraska, United States

Galderma Investigational Site 8740

Henderson, Nevada, United States

Galderma Investigational Site 8825

Las Vegas, Nevada, United States

Galderma Investigational Site 8675

Las Vegas, Nevada, United States

Galderma Investigational Site 8109

Lebanon, New Hampshire, United States

Galderma Investigational Site 8506

Hackensack, New Jersey, United States

Galderma Investigational Site 8826

Albuquerque, New Mexico, United States

Galderma Investigational Site 8242

Brooklyn, New York, United States

Galderma Investigational Site 8741

Buffalo, New York, United States

Galderma Investigational Site 8723

Cortland, New York, United States

Galderma Investigational Site 8828

Forest Hills, New York, United States

Galderma Investigational Site 9925

Glendale, New York, United States

Galderma Investigational Site 8733

New York, New York, United States

Galderma Investigational Site 8620

New York, New York, United States

Galderma Investigational Site 8279

New York, New York, United States

And 243 more locations on ClinicalTrials.gov